CytomX Therapeutics CTMX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's operating margin?
- CytomX Therapeutics (CTMX) reported operating margin of -181.9% in Q1 2026.
- How has CytomX Therapeutics's operating margin changed year-over-year?
- CytomX Therapeutics's operating margin decreased by 846.5% year-over-year, from 24.4% to -181.9%.
- What is the long-term trend for CytomX Therapeutics's operating margin?
- Over 5 years (2020 to 2025), CytomX Therapeutics's operating margin has grown at a -24.3% compound annual growth rate (CAGR), from -117.7% to -29.4%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.